LIN vs TKNO · P/E 34, rev $33.99B vs rev $37.7M
Linde plc Ordinary Shares (LIN) versus Alpha Teknova Inc (TKNO) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Alpha Teknova Inc (TKNO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported TKNO revenue for 2024-12-31 was $37.7M. Net income was -$26.7M. Revenue was up 2.9% from 2023-12-31 to 2024-12-31. TKNO currently screens at market cap $221.4M.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. TKNO currently screens at market cap $221.4M.
Not investment advice. Open the LIN and TKNO stock pages for the full models.
Not investment advice.